Increased blaOXA-23-like prevalence in Acinetobacter baumannii at a tertiary care center in Lebanon (2007-2013) | Zendy

Souha S. Kanj | Zendy; Ralph Tayyar | Zendy; Marwa Shehab | Zendy; Bassam El Hafi | Zendy; Sari Rasheed | Zendy; Kohar Annie B. Kissoyan | Zendy; Zeina A. Kanafani | Zendy; Rima Hanna Wakim | Zendy; Nada Zahreddine | Zendy; George F. Araj | Zendy; Ghassan Dbaibo | Zendy; Ghassan M Matar | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Increased blaOXA-23-like prevalence in Acinetobacter baumannii at a tertiary care center in Lebanon (2007-2013)

Author(s) -

Souha S. Kanj,

Ralph Tayyar,

Marwa Shehab,

Bassam El Hafi,

Sari Rasheed,

Kohar Annie B. Kissoyan,

Zeina A. Kanafani,

Rima Hanna Wakim,

Nada Zahreddine,

George F. Araj,

Ghassan Dbaibo,

Ghassan M Matar

Publication year - 2018

Publication title -

the journal of infection in developing countries

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.322

H-Index - 49

eISSN - 2036-6590

pISSN - 1972-2680

DOI - 10.3855/jidc.9642

Subject(s) - acinetobacter baumannii , biology , outbreak , drug resistance , microbiology and biotechnology , tertiary care , rapd , antibiotic resistance , carbapenem , antibiotics , medicine , virology , genetics , emergency medicine , bacteria , pseudomonas aeruginosa , environmental health , population , genetic diversity

Acinetobacter baumannii has become one of the most feared organisms in hospital-acquired infections during the past decades. Their multi-drug resistant profiles have rendered many broad-spectrum antibiotics ineffective. The purpose of this retrospective study is to describe and compare molecular characteristics of A. baumannii isolated from patients at a tertiary care center in Lebanon from two outbreaks, the first in 2007-2008 as part of a case-controlled study involving Acinetobacter baumannii cases admitted to the ICU and the second in 2013.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research